RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Endocrine disruptorse modificazioni delle funzioni neuroendocrine,metaboliche e del comportamento:ruolo della somministrazione bifeniili policlorurati(PCB)durante lo sviluppo
• 2 - Ruolo di citochine ed ormoni di origine gastrointestinale ed adipocitaria nella patogenesi dell'obesità e delle sue complicanze
• 3 - RUOLO DELLE CELLULE DENDRITICHE, DELLE CITOCHINE E DEGLI ORMONI STEROIDEI SESSUALI NELLA STORIA NATURALE DELLE MALATTIE EPATICHE CRONICHE
• 4 - Sviluppo e progressione del carcinoma epatocellulare: meccanismi molecolari ed implicazioni terapeutiche
• 5 - Ruolo dell'FGFR2 e di altri cofattori nell'etiopatogenesi di tumori epiteliali.
• 6 - Ruolo patogenetico del Brain-derived neurotrophic factor (BDNF) nell'eziologia delle patologie neurodegenerative: dai modelli animali allo studio nell'uomo.
• 7 - Ghrelin: azioni periferiche su tessuti, ormoni e metabolismo.
• 8 - Effetti clinici e molecolari dell'eccesso di glucocorticoidi
• 9 - Studio degli effetti genomici dell'aldosterone in modelli cellulari ed in vivo.
• 10 - Nuove acquisizioni sulla fisiopatologia e sulla terapia dell'endometriosi

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • GENETICA MEDICA
  • ENDOCRINOLOGIA
  • REUMATOLOGIA
  • PEDIATRIA GENERALE E SPECIALISTICA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
    • STEROIDS (Seco-steroids C07C)
• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Emilia Romagna

Bibliografia

1)Gruber CJ,Tschugguel W,Schneeberger C,et al 2002 Mechanisms of Disease: Production and Actions of Estrogens.N Engl J Med 346:340
2)Carani C,Qin K,Simoni M,et al 1997 Effect of testosterone and estradiol in a man with aromatase deficiency.N Engl J Med 337:91
3)Faustini-Fustini M,Rochira V,Carani C 1999 Oestrogen deficiency in men: where are we today? Eur J Endocrinol 140:111
4)Grumbach MM,Auchus RJ 1999 Estrogen: consequences and implications of human mutations in synthesis and action.J Clin Endocrinol Metab 84:4677
5)Couse JF,Korach KS 1999 Estrogen receptor null mice:what have we learned and where will they lead us?Endocr Rev 20:358
6)Enmark E,Gustafsson JA 1999 Oestrogen receptors-an overview.J Internal Med 246:133
7)Levin ER. 1999 Cellular functions of the plasma membrane estrogen receptor.Trends Endocrinol Metab 10:374
8)Simpson ER,Mahendroo MS,Means GD,et al 1994 Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis.Endocrine Reviews 15:342
9)Corbin CJ,Graham-LorenceS,McPhaul M,et al 1988 Isolation of a full length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in non-steroidogenic cells.Proceeding of the National Academy of Sciences of U.S.A. 85:8948
10) Larionov AA,Vasyliev DA,Mason JI,et al 2003 Aromatase in skeletal muscle.J Steroid Biochem Mol Biol 84:485
11)Shozu M,Zhao Y,Bulun SE,et al 1998 Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6.Endocrinology 139:1610
12)Simpson ER, Michael MD, Agarwal VR, et al 1997 Expression of the CYP19 (aromatase) gene: an unusual case of alternative promoter usage. FASEB Journal 11:29
13) Bulun SE, Sebastian S, Takayama K, et al 2003 The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Teroid biochem Mol Biol 86:219
14)Berstein LM, Santner SJ, Brodie AM, et al 1993 "Pseudoaromatase in circulating lymphocytes." J Steroid Biochem Mol Biol 44:647
15)Berstein LM, Larionov AA, Poroshina TE, et al 2002 Aromatase (CYP19) expression in tumor-infiltrating lymphocytes and blood mononuclears. J Cancer Res Clin Oncol 128:173
16)Vottero A, Kirschner LS, Yue W, et al 1998 "P450arom gene expression in peripheral blood lymphocytes: identification of a cryptic splice site for exon-1 after Epstein-Barr virus transformation." J Steroid Biochem Mol Biol 64:245
17)Shozu M, Sumitani H, Murakami K, et al 2001 Regulation of aromatase activity in bone-derived cells: possible role of mitogen-activated protein kinase. J Steroid Biochem Mol Biol 79:61
18)Smith EP, Boyd J, Frank GR, et al 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056
19)Morishima A, Grumbach MM, Simpson ER, et al 1995 Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689
20)Carani C, Rochira V, Faustini-Fustini M, et al 1999 Role of estrogen in male sexual behaviour: insights from the natural model of aromatase deficiency. Clin Endocrinol 51:517
21) Herrmann BL, Saller B, Janssen OE, et al 2002 Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab 87:5476
22) Maffei L, Murata Y, Rochira V, et al 2004 J Clin Endocrinol Metab 89:61
23)Rochira V, Faustini-Fustini M, Balestrieri A, et al 2000 Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters. J Clin Endocrinol Metabol 85:1841
24)Rochira V, Balestrieri A, Faustini-Fustini M, et al 2001 Role of estrogen on bone in the human male: insights freom the natural models of congenital estrogen deficiency. Mol Cell Endocrinol 178;215
25) Khosla S, Melton LJ 3rd, Riggs BL 2002 Clinical review 144: estrogen and the male skeleton. J Clin Endocrinol Metab. 87:1443
26)Rochira V, Balestrieri A, Madeo B, et al 2002 Congenital estrogen deficiency in men: a new syndrome with different phenotypes, clinical and therapeutic implications in men. Mol Cell Endocrinol 193:19
27)Laue L, Kenigsberg D, Pescovitz OH, et al 1989 Treatment of familial male precocious puberty with spironolactone and testolactone. N Engl J Med 320:496
28)Oz OK, Millsaps R, Welch R, et al 2001 Expression of aromatase in the human growth plate. J Mol Endocrinol 27:249
29)Rochira V 2001 Letters to the editor: Aromatase inhibitors in pubertal boys: clinical implications. J Clin Endocrinol Metab 86:1836
30)Carani C., Granata AR, Rochira Vet al. (2005). Sex steroids and sexual desire in a man with a novel mutation of aromatase gene and hypogonadism. PSYCHONEUROENDOCRINOLOGY. vol. 30 pp. 413-417
31)Rochira V, Balestrieri A, Faustini-Fustini M, et al 2002 Pituitary function in a man with congenital aromatase deficiency: effect of different doses of transdermal estradiol on basal and sitmulated pituitary hormones. J Clin Endocr Metab 87:2857
32)Kerrigan JR, Rogol AD 1992 The impact of gonadal steroid hormone action on growth hormone secretion during chidhood and adolescence. Endocr Rev 13:281
33)Rose SR, Municchi G, Barnes KM, et al 1991 Spontaneous growth hormone secretion increases during puberty in normal girls and boys. J Clin Endocrinol Metab 73:428
34)Veldhuis JD, Metzger DL, Martha PM Jr,et al 1997 Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 82:3414
35)Mauras N 2001 Growth hormone and sex steroids. Interactions in puberty. Endocrinol Metab Clin North Am 30:529
36)Weise M, De-Levi S, Barnes KM, et al 2001 Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci 98:6871
37)Klein KO, Baron J, Colli MJ, et al 1994 Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest 94:2475
38)Veldhuis JD, Roemmich JN, Rogol AD 2000 Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females-a general clinical research center-based study. J Clin Endocrinol Metab 85:2385
39)Adashi EY, Resnick CE, Brodie AMH, et al 1985 Somatomedin-C mediated potentiation of follicle stimulating hormone-induced aromatase activity of cultured rat granulose cells. Endocrinology 117:2313
40)Barreca A, Del Monte P, Ponzani P, et al 1996 Intrafollicular insulin-like growth factor-IIlevels in normally ovulating women and in patients with polycystic ovary syndrome. Fertil Steril. 65:739
41)Barreca A, Artini PG, Cesarone A, et al 1996 Interrelationships between follicle stimulating hormone and the growth hormone--insulin-like growth factor--IGF-binding proteins axes in human granulosa cells in culture. J Endocrinol Invest 19:35
42)Barreca A, Artini PG, Del Monte P, et al 1993 In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells. J Clin Endocrinol Metab 77:61
43)Ansar AS, Penhale WJ, Talal N 1985 Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 121:531
44)Mogensen EF, Green A 1980 The epidemiology of thyrotoxicosis in Denmark. Incidence and geographical variation in the Funen region 1972-1974. Acta Med Scand 208:183
45)Krishnan AV, Swami S, Feldman D 2001 Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells. JSteroid Biochem Mol 77:29
46) Kinyamu HK, Archer TK 2003 Estrogen receptor-dependant proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression. Mol Cell Biol 23:5867

Parole Chiave

AROMATASI; ESTROGENI; ESPRESSIONE GENICA; SISTEMA GH-IGF1; LEUCOCITI; IPOGONADISMO; SISTEMA IMMUNITARIO; RECETTORI PER I GLUCOCORTICOIDI; OSTEOBLASTI